Medullary Thyroid Carcinoma (MTC) and MEN2 MTC is rare, creating two realities: If a causal effect were large, it might be detectable in very large datasetsbut evidence has not established such a signal If a causal effect were small, enormous follow-up and careful subtype adjudication would be required Because the boxed warning is MTC/MEN2-specific, a conservative clinical approach is appropriate: Avoid GLP-1 RAs in patients with personal or family history of MTC Avoid GLP-1 RAs in MEN2 The Evidence by Subtype: For common thyroid cancers, the best evidence doesn't show causation
BPC-157 Benefits Rapid healing of soft tissue injuries Accelerated tendon, ligament, and joint repair Reduced inflammation and swelling in injured areas Improved flexibility, mobility, and tissue elasticity Gut lining protection and ulcer repair Potential neurological healing properties No hormonal suppression or systemic endocrine impact Extremely well-tolerated in research models BPC-157 Dosage (Research Purposes Only) Standard Dosage : 250mcg to 500mcg daily Advanced Dosage : Up to 1,000mcg daily for intensive recovery protocols Administration : Subcutaneous injection (systemic or near injury site) Cycle Length : 4 to 8 weeks depending on injury severity and research model Many protocols combine BPC-157 with TB-500 for synergistic tissue repair studies
Yes, but start slow
Vitamin C injections improve overall skin appearance by reducing wrinkles, diminishing pigment spots, and imparting a youthful glow
Her field of view tests has improved by at least 50%
